Annual Report

Overview

The report describes Pharmstandard's strong 2011 growth, including consolidated revenue of RUR 42,653.9 million and the integration of Ukrainian pharmaceutical company PJSC Pharmstandard-Biolik. It highlights the manufacture of four new products and the completed Generium R&D centre. The group reported 5,966 full-time employees at year-end and described employee social support, health protection, and insurance programs.

Document

Report type: Annual Report
Class: Financial
Scope: Full report
Fiscal year: 2011
Period: Ends 31 December 2011
Publication date: 23 April 2012
Language: English
Pages
File size

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services